DK1268558T3 - Derivater af delvist desulfaterede glycosaminoglycaner forsynet med antiangionisk aktivitet og uden antikoagulerende virkning - Google Patents

Derivater af delvist desulfaterede glycosaminoglycaner forsynet med antiangionisk aktivitet og uden antikoagulerende virkning

Info

Publication number
DK1268558T3
DK1268558T3 DK01906098T DK01906098T DK1268558T3 DK 1268558 T3 DK1268558 T3 DK 1268558T3 DK 01906098 T DK01906098 T DK 01906098T DK 01906098 T DK01906098 T DK 01906098T DK 1268558 T3 DK1268558 T3 DK 1268558T3
Authority
DK
Denmark
Prior art keywords
activity
derivatives
antiangionic
anticoagulant effect
partially desulfated
Prior art date
Application number
DK01906098T
Other languages
English (en)
Inventor
Benito Casu
Giangiacomo Torri
Anna Maria Naggi
Giuseppe Sigma-Tau Giannini
Claudio Sigma-Tau Pisano
Sergio Penco
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Application granted granted Critical
Publication of DK1268558T3 publication Critical patent/DK1268558T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Obesity (AREA)
  • Ophthalmology & Optometry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK01906098T 2000-01-25 2001-01-24 Derivater af delvist desulfaterede glycosaminoglycaner forsynet med antiangionisk aktivitet og uden antikoagulerende virkning DK1268558T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2000RM000041A IT1316986B1 (it) 2000-01-25 2000-01-25 Derivati glicosamminoglicani parzialmente desolfatati nonanticoagulanti ad attivita' antiangiogenica.
PCT/IT2001/000034 WO2001055221A1 (en) 2000-01-25 2001-01-24 Derivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect

Publications (1)

Publication Number Publication Date
DK1268558T3 true DK1268558T3 (da) 2007-04-10

Family

ID=11454382

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01906098T DK1268558T3 (da) 2000-01-25 2001-01-24 Derivater af delvist desulfaterede glycosaminoglycaner forsynet med antiangionisk aktivitet og uden antikoagulerende virkning

Country Status (22)

Country Link
US (4) US20030013682A1 (da)
EP (1) EP1268558B1 (da)
JP (1) JP5371167B2 (da)
KR (1) KR100812406B1 (da)
CN (1) CN100540570C (da)
AT (1) ATE348115T1 (da)
AU (1) AU782632B2 (da)
BR (1) BR0107696A (da)
CA (1) CA2397964C (da)
CY (1) CY1108001T1 (da)
CZ (1) CZ303030B6 (da)
DE (1) DE60125154T2 (da)
DK (1) DK1268558T3 (da)
ES (1) ES2277911T3 (da)
HK (1) HK1051867A1 (da)
HU (1) HU229509B1 (da)
IT (1) IT1316986B1 (da)
MX (1) MXPA02007195A (da)
PL (1) PL209479B1 (da)
PT (1) PT1268558E (da)
SK (1) SK287566B6 (da)
WO (1) WO2001055221A1 (da)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1316986B1 (it) 2000-01-25 2003-05-26 Sigma Tau Ind Farmaceuti Derivati glicosamminoglicani parzialmente desolfatati nonanticoagulanti ad attivita' antiangiogenica.
US7781416B2 (en) 2000-01-25 2010-08-24 Sigma-Tau Research Switzerland S.A. Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect
CA2457719C (en) * 2001-09-12 2012-01-03 Benito Casu Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect
AU2008202261B2 (en) * 2001-09-12 2011-07-28 Leadiant Biosciences S.A. Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect
CA2582428A1 (en) 2004-03-26 2005-10-13 Glycogenesys, Inc. Modified pectins, compositions and methods related thereto
WO2009007224A1 (en) * 2007-07-10 2009-01-15 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Low molecular weight heparin derivatives having neuroprotective activity
KR101561860B1 (ko) * 2007-11-02 2015-10-20 모멘타 파머슈티컬스 인코포레이티드 비항응고성 다당류 조성물
US8592393B2 (en) 2007-11-02 2013-11-26 Momenta Pharmaceuticals, Inc. Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
US8569262B2 (en) 2007-11-02 2013-10-29 Momenta Pharmaceuticals, Inc. Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
ES2567079T3 (es) 2007-11-02 2016-04-19 Momenta Pharmaceuticals, Inc. Composiciones de polisacáridos que no son anticoagulantes
US9387256B2 (en) 2010-04-16 2016-07-12 Momenta Pharmaceuticals, Inc. Tissue targeting
US8431826B2 (en) 2010-05-14 2013-04-30 James Robert Howard Capacitive power and ground plane structure utilizing fractal elements for the reduction of radiated emissions
AU2011268470B2 (en) 2010-06-17 2017-02-02 Momenta Pharmaceuticals, Inc. Methods and compositions for promoting hair growth
LT2794665T (lt) 2011-12-19 2017-12-27 Dilafor Ab Neantikoaguliaciniai glikozaminoglikanai, apimantys pasikartojantį disacharido vienetą, ir jų medicininis panaudojimas
WO2013095215A1 (en) 2011-12-19 2013-06-27 Dilaforette Ab Low anticoagulant heparins
BR112014015940B1 (pt) 2011-12-28 2022-08-09 Galectin Therapeutics, Inc Polissacarídeo de grau farmacêutico, composição, e seus usos
KR102071739B1 (ko) 2012-06-06 2020-01-30 갈렉틴 테라퓨틱스, 인크. 상승된 유도성 산화 질소 합성효소와 연관된 질환의 치료를 위한 갈락토-람노갈락투로네이트 조성물
US9507912B2 (en) 2012-08-31 2016-11-29 Nuvectra Corporation Method and system of simulating a pulse generator on a clinician programmer
US9872909B2 (en) 2012-09-17 2018-01-23 Galeotin Therapeutics, Inc. Method for enhancing specific immunotherapies in cancer treatment
CN104822382B9 (zh) 2012-10-10 2019-01-18 卡莱克汀医疗有限公司 用于治疗糖尿病性肾病和相关疾病的半乳糖分支的糖类化合物
WO2014130648A1 (en) 2013-02-20 2014-08-28 Galectin Therapeutics, Inc. Method for treatment of pulmonary fibrosis
JP2016520613A (ja) 2013-05-28 2016-07-14 モメンタ ファーマシューティカルズ インコーポレイテッド 薬学的組成物
JP6132302B2 (ja) * 2013-05-28 2017-05-24 リーディアント・バイオサイエンシーズ・ソシエタ・アノニマＬｅａｄｉａｎｔ Ｂｉｏｓｃｉｅｎｃｅｓ Ｓ．Ａ． 抗血管新生活性を有し、抗凝血効果を有さない、ヘパラナーゼ阻害剤としての部分的に脱硫酸化されたグリコサミノグリカンの誘導体
ITLO20130005A1 (it) 2013-10-31 2015-05-01 He E Biochimiche G Ronzonr S R Derivati di glucosamminoglicani n-desolfatati e loro uso come farmaci
ITLO20130006A1 (it) 2013-11-06 2015-05-07 He E Biochimiche G Ronzoni S R Derivati carbossilati di glucosamminoglicani e loro uso come farmaci
CN103724458B (zh) * 2014-01-17 2016-03-30 福州大学 含n-非取代葡萄糖胺肝素六糖的制备及其纯化
MX2017011093A (es) 2015-03-06 2018-02-19 Leadiant Biosciences S A Terapia combinada de roneparstat para mieloma multiple.
JP2016014148A (ja) * 2015-09-10 2016-01-28 シグマ−タウ・リサーチ・スウィッツァーランド・ソシエテ・アノニム 抗血管新生活性を有し、抗凝血効果を有さない、ヘパラナーゼ阻害剤としての部分的に脱硫酸化されたグリコサミノグリカンの誘導体
CN107177015A (zh) * 2016-03-11 2017-09-19 梁颖 一种重乙酰化肝素修饰物及其制备方法和应用
US11787783B2 (en) 2016-12-13 2023-10-17 Beta Therapeutics Pty Ltd Heparanase inhibitors and use thereof
KR20190093214A (ko) 2016-12-13 2019-08-08 베타 테라퓨틱스 피티와이 리미티드 헤파라나제 억제제 및 그의 용도
CN108424474B (zh) * 2017-02-15 2023-07-25 清华大学 去抗凝肝素衍生物及其用于炎症性肠病的治疗
US11225531B2 (en) 2018-02-02 2022-01-18 Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Glycosaminoglycan derivative and preparation method therefor and use thereof
EP3705126A1 (en) 2019-03-05 2020-09-09 Leadiant Biosciences S.p.A. Roneparstat for the treatment of amyloidosis
CN114901702B (zh) * 2019-12-27 2024-01-09 深圳市海普瑞药业集团股份有限公司 一种糖胺聚糖衍生物及其应用

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4500519A (en) * 1978-11-06 1985-02-19 Choay S.A. Mucopolysaccharides having biological properties, preparation and method of use
US5262403A (en) 1986-03-10 1993-11-16 Board Of Regents, The University Of Texas System Glycosaminoglycan derivatives and their use as inhibitors of tumor invasiveness of metastatic profusion-II
IL79255A0 (en) 1986-06-26 1986-09-30 Hadassah Med Org Composition for metastasis prevention
AU7852687A (en) * 1986-08-21 1988-03-08 University Of Texas System, The Glycosaminoglycan derivatives and their use as inhibitors of tumor invasiveness or metastatic profusion
FR2614026B1 (fr) * 1987-04-16 1992-04-17 Sanofi Sa Heparines de bas poids moleculaire, a structure reguliere, leur preparation et leurs applications biologiques
US5280016A (en) * 1991-03-29 1994-01-18 Glycomed Incorporated Non-anticoagulant heparin derivatives
JPH05157344A (ja) * 1991-12-09 1993-06-22 Mitsubishi Heavy Ind Ltd 空気調和機の吹出口
JPH0512822A (ja) 1991-12-16 1993-01-22 Seiko Epson Corp カートリツジ
JPH06157344A (ja) * 1992-02-07 1994-06-03 Childrens Medical Center Corp:The 血管新生阻害のための医薬製剤及び血管新生阻害方法
US5668118A (en) * 1992-07-24 1997-09-16 Cavalier Pharmaceuticals Method of synthesis of 2-O-desulfated Heparin and use thereof for inhibition of elastase and Cathepspin G
US5696100A (en) * 1992-12-22 1997-12-09 Glycomed Incorporated Method for controlling O-desulfation of heparin and compositions produced thereby
US5296471A (en) 1992-12-22 1994-03-22 Glycomed Incorporated Method for controlling o-desulfation of heparin and compositions produced thereby
IT1264709B1 (it) 1993-07-12 1996-10-04 Italfarmaco Spa Derivati eparinici ad attivita' antimetastatica
US5583121A (en) * 1994-01-12 1996-12-10 Michigan State University Non-anticoagulant chemically modified heparinoids for treating hypovolemic shock and related shock syndromes
AU2435795A (en) * 1994-05-06 1995-11-29 Glycomed Incorporated O-desulfated heparin derivatives, methods of making and uses thereof
IL114951A (en) * 1995-08-15 1999-08-17 Hadasit Med Res Service Quinazolinone-containing pharmaceutical compositions for prevention of neovascularization
US5854221A (en) * 1996-12-12 1998-12-29 The Children's Medical Center Corporation Endothelial cell proliferation inhibitor and method of use
PT876366E (pt) * 1996-01-15 2002-01-30 Janssen Pharmaceutica Nv Piridazinaminas inibidoras da angiogenese
JP4051099B2 (ja) * 1997-01-31 2008-02-20 生化学工業株式会社 低分子化ヘパリン、その製造法及び医薬組成物
IT1296581B1 (it) 1997-11-28 1999-07-14 Istituto Scient Di Chimica E B Materiali polimerici non trombogenici e ad esaltata compatibilita' con fluidi e tessuti organici
IT1296998B1 (it) * 1997-12-19 1999-08-03 Derivati Organici Lab Composizione costituita da frazioni di eparina avente caratteristiche riproducibili con peso molecolare medio di 5200 d
US7781416B2 (en) * 2000-01-25 2010-08-24 Sigma-Tau Research Switzerland S.A. Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect
IT1316986B1 (it) * 2000-01-25 2003-05-26 Sigma Tau Ind Farmaceuti Derivati glicosamminoglicani parzialmente desolfatati nonanticoagulanti ad attivita' antiangiogenica.

Also Published As

Publication number Publication date
CZ303030B6 (cs) 2012-03-07
ATE348115T1 (de) 2007-01-15
CA2397964A1 (en) 2001-08-02
US20100298263A1 (en) 2010-11-25
HK1051867A1 (en) 2003-08-22
CN100540570C (zh) 2009-09-16
MXPA02007195A (es) 2003-01-28
DE60125154T2 (de) 2007-10-25
HUP0204196A2 (hu) 2003-03-28
US8222231B2 (en) 2012-07-17
KR20020080381A (ko) 2002-10-23
ITRM20000041A0 (it) 2000-01-25
US20030013682A1 (en) 2003-01-16
KR100812406B1 (ko) 2008-03-11
AU782632B2 (en) 2005-08-18
PL357209A1 (en) 2004-07-26
CA2397964C (en) 2010-10-12
JP2003523460A (ja) 2003-08-05
WO2001055221A1 (en) 2001-08-02
DE60125154D1 (de) 2007-01-25
ES2277911T3 (es) 2007-08-01
ITRM20000041A1 (it) 2001-07-25
IT1316986B1 (it) 2003-05-26
EP1268558A1 (en) 2003-01-02
US20050107331A1 (en) 2005-05-19
JP5371167B2 (ja) 2013-12-18
HUP0204196A3 (en) 2003-05-28
SK287566B6 (sk) 2011-02-04
HU229509B1 (en) 2014-01-28
SK10672002A3 (sk) 2002-12-03
CY1108001T1 (el) 2013-09-04
PL209479B1 (pl) 2011-09-30
CZ20022308A3 (cs) 2003-01-15
AU3406401A (en) 2001-08-07
BR0107696A (pt) 2002-10-15
US7790700B2 (en) 2010-09-07
US20050222084A1 (en) 2005-10-06
EP1268558B1 (en) 2006-12-13
CN1396930A (zh) 2003-02-12
PT1268558E (pt) 2007-02-28

Similar Documents

Publication Publication Date Title
DK1268558T3 (da) Derivater af delvist desulfaterede glycosaminoglycaner forsynet med antiangionisk aktivitet og uden antikoagulerende virkning
HK1069537A1 (en) Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect
PT1140944E (pt) Derivados de epotilona e sua utilizacao como agentes antitumorais
BR9916111A (pt) Derivados de fenilglicina
PT1112275E (pt) Novos inibidores heteroaromaticos da frutose-1,6-bisfosfatase
DK125796A (da) I form af små molekyler foreliggende inhibitorer for rotamaseaktivitet
NO20006323L (no) Glykopeptid-derivater og farmasöytiske sammensetninger som inneholder disse
EA200300836A1 (ru) Производные фталазинон-пиперидина в качестве ингибиторов pde4
NO20021379L (no) Benzodiazepin-derivater, fremstilling og anvendelse derav
YU21401A (sh) Tetrahidropiridoetri
MXPA02012042A (es) Compuestos efectivos como agonistas de beta-2-adrenorreceptor, y como inhibidores de pde4.
NO20014756D0 (no) C(10)-heterosubstituerte acetattaksaner som antitmormidler
IT1290814B1 (it) Glicosaminoglicani aventi elevata attivita' antitrombotica
TR200100133T2 (tr) FKBP İnhibitörleri
TR200402343T4 (tr) Antitrombotik ve antikoagulant etken olarak kullanım için N-(Heterosiklil) benzen veya piridin sulfonamit
DK1244643T3 (da) Tryptaseinhibitorer
DE60011300D1 (de) Inhibitoren der tryptase
DK1240313T3 (da) Enzymer, som er homologe med heparanase og splejsningsvarianter deraf
PA8478901A1 (es) Isoquinolinas
TR200002749T2 (tr) Antibiyotikler olarak siklik aminoguanidin substitüentlerine sahip sefalosporinler.
PT937075E (pt) Novas imidazo- e oxazolo-piridinas como inibidores da fosfodiesterese
FR2774380B1 (fr) Cellulose de parenchyme substituee par des groupements carboxyalkyle
ATE348803T1 (de) Tryptase-inhibitoren
BR9915965A (pt) Benzilmaltosìdeos de acetal como inibidores da proliferação celular do músculo liso
DK1358182T3 (da) Diazocin-derivater og anvendelsen deraf som tryptase-inhibitorer